Characterization of inhibitory anti-insulin-like growth factor receptor antibodies with different epitope specificity and ligand-blocking properties: implications for mechanism of action in vivo.

MLA

Doern, Adam, et al. “Characterization of Inhibitory Anti-Insulin-like Growth Factor Receptor Antibodies with Different Epitope Specificity and Ligand-Blocking Properties: Implications for Mechanism of Action in Vivo.” The Journal of Biological Chemistry, vol. 284, no. 15, Apr. 2009, pp. 10254–67. EBSCOhost, https://doi.org/10.1074/jbc.M809709200.

APA

Doern, A., Cao, X., Sereno, A., Reyes, C. L., Altshuler, A., Huang, F., Hession, C., Flavier, A., Favis, M., Tran, H., Ailor, E., Levesque, M., Murphy, T., Berquist, L., Tamraz, S., Snipas, T., Garber, E., Shestowsky, W. S., Rennard, R., … Hariharan, K. (2009). Characterization of inhibitory anti-insulin-like growth factor receptor antibodies with different epitope specificity and ligand-blocking properties: implications for mechanism of action in vivo. The Journal of Biological Chemistry, 284(15), 10254–10267. https://doi.org/10.1074/jbc.M809709200

Chicago

Doern, Adam, Xianjun Cao, Arlene Sereno, Christopher L Reyes, Angelina Altshuler, Flora Huang, Cathy Hession, et al. 2009. “Characterization of Inhibitory Anti-Insulin-like Growth Factor Receptor Antibodies with Different Epitope Specificity and Ligand-Blocking Properties: Implications for Mechanism of Action in Vivo.” The Journal of Biological Chemistry 284 (15): 10254–67. doi:10.1074/jbc.M809709200.